image description

Tag: lupus research alliance

2022 United Airlines New York City Half-Marathon

March 20, 2022 marks the first return of the NYC Half Marathon since the COVID-19 pandemic cancelled the race in 2020. The Lupus Research Alliance Team Life Without Lupus® could not be more proud and excited to take part in this milestone event. Join our Team and apply here for one of LRA’s Guaranteed Spots […] Read More

Kudos to Board Member Nadeem Meghji

Kudos to Board Member Nadeem Meghji May 9, 2018 Congratulations to Lupus Research Alliance Board member Nadeem Meghji for being chosen to join the World Economic Forum’s community of Young Global Leaders! Mr. Meghji is among 100 of the world’s most promising artists, business leaders, public servants, technologists and social entrepreneurs comprising this prestigious group. In […] Read More

Lupus Research Alliance Grants $6 Million in First Global Team Science Awards

This Largest-Ever Grant Will Fund Two Projects Examining Why Lupus Differs for Each Person NEW YORK, NY. Sept. 21. Today, the Lupus Research Alliance is pleased to announce the inaugural recipients of its largest grant to date, the Global Team Science Award, which will fund international, multidisciplinary research teams to unravel lupus heterogeneity with the […] Read More

Department of Defense Lupus Research Program Supported in New Bill

June 13, 2018 Our advocates knocked on Capitol doors in March with requests to robustly fund the Lupus Research Program first established last year within the Defense Department’s Congressionally Directed Medical Research Programs. And our nation’s legislators listened! As a result of advocacy by lupus patients, organizations like the Lupus Research Alliance and supportive Members […] Read More

Important Message from CEO Kenneth Farber: U.S. FDA Approves New Lupus Treatment

August 2, 2021 Dear Friend of the Lupus Research Alliance, As we reported this morning, the lupus community has much to celebrate with the U.S. Food and Drug Administration (FDA) approval of anifrolumab-fnia (brand name, Saphnelo™). As a first-in-class and only new treatment for systemic lupus erythematosus in a decade, this approval marks a major […] Read More

President Signs Bill that Advances Lupus Research and Care

May 5, 2017. NEW YORK, NY. A bipartisan spending bill for Fiscal 2017 that includes key provisions the Lupus Research Alliance and lupus advocates across the country have fought for was signed into law today. The bill establishes for the first time an annual $5 million lupus medical research program at the Department of Defense […] Read More

LRA is Unraveling Lupus Heterogeneity to Turn Complexity to Cure

July 22, 2021 Why is lupus so tough to treat? Why is it so difficult to test possible new treatments in a clinical trial? Why are so many people needed for a clinical trial to prove effectiveness? And how does LRA intend to Turn Lupus Complexity to Cure? The answers lie at the core of […] Read More

Promising New Lupus Treatments Highlighted ACR Annual Meeting

Results of clinical trials testing potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR Convergence 2020. These studies include phase I trials, which test for side effects and a safe dosage; larger phase II trials, which test for effectiveness and further gauge safety; and large phase III trials, which confirm […] Read More